Eton Phar­ma hand­ed CRL for re­for­mu­lat­ed con­junc­tivi­tis eye drop

Eton Phar­ma’s grand plan to launch an over-the-counter for an oc­u­lar itch that of­ten af­flicts chil­dren has hit a dead end at the FDA, which …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA